Dorsey Brian 4
4 · ARS Pharmaceuticals, Inc. · Filed Aug 15, 2024
Insider Transaction Report
Form 4
Dorsey Brian
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-08-13−30,000→ 111,828 totalExercise: $0.64Exp: 2028-11-28→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2024-08-13$0.64/sh+30,000$19,200→ 36,024 total - Sale
Common Stock
2024-08-13$13.00/sh−30,000$390,000→ 6,024 total
Footnotes (3)
- [F1]Includes 2,159 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan ("ESPP") on June 30, 2023, 1,013 shares acquired under the ESPP on December 29, 2023 and 2,852 shares acquired under the ESPP on June 29, 2024.
- [F2]The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2023.
- [F3]Immediately exercisable.